Pathstone Holdings, LLC Ptc Therapeutics, Inc. Transaction History
Pathstone Holdings, LLC
- $22.3 Billion
- Q3 2024
A detailed history of Pathstone Holdings, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 6,968 shares of PTCT stock, worth $306,801. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,968
Previous 7,352
5.22%
Holding current value
$306,801
Previous $224,000
15.18%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PTCT
# of Institutions
229Shares Held
79.1MCall Options Held
164KPut Options Held
220K-
Vanguard Group Inc Valley Forge, PA9.13MShares$402 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$348 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$342 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$326 Million4.37% of portfolio
-
Armistice Capital, LLC New York, NY7.23MShares$319 Million4.46% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.15B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...